Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Neurology

Topics

Engineering

Epidemiology

Medicine

Internal Medicine

Cardiology

Show all topics

DOI

10.1016/s1474-4422(24)00206-0